Apimeds Pharmaceuticals US Ratios (2023-2025) | APUS

Ratios Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Efficiency
Assets Average (Quarter) 0.14M5.40M9.90M86.72M
Equity Average (Quarter) -0.12M-0.49M-0.88M-1.20M-1.56M3.99M8.95M80.75M
Invested Capital (Quarter) 0.03M-0.26M-0.71M-1.05M-1.36M-1.76M9.74M8.16M154.96M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -10.10-19.34-9.19-7.65-9.58-115.55-292.69-32.65
Debt to Equity (Quarter) -0.140.01
Debt Ratio (Quarter) 0.960.01
Equity Ratio (Quarter) 0.08-104.01-6.770.920.880.93
Times Interest Earned (Quarter) -10.10-19.34-9.19-7.65-9.58-115.55-292.69-32.65
Valuation
Enterprise Value (Quarter) -0.41M-0.00M-0.25M-8.74M-6.99M-3.64M
Return Ratios
Return on Capital Employed (Quarter) 83.71%-78.44%-58.44%-15.67%
Return on Assets (Quarter) -0.11%-0.01%-0.01%0.00%
Return on Equity (Quarter) 0.01%0.01%0.01%-0.01%-0.01%0.00%